People lose muscle and can potentially lose bone, which is why working with professionals is so important
Severe but Rare Complications of GLP-1 and Peptide Therapy Pancreatitis and Gallbladder Problems Some studies suggest a link between GLP-1 therapies and acute pancreatitis or gallstones
Data Charting Relevant information from each included study was extracted using a data charting form that captured the following fields: author(s), year of publication, country of origin, whether the combination was an add-on or simultaneously used, study population characteristics relevant to the outcomes, and sample size, study design, intervention or exposition type and details of these, comparator, outcomes and their specifics, adverse effects reports, and key findings related to the scoping review questions
Germany Focuses on Private Sector Treatment Access Demand for obesity GLP-1 treatment in Germany is projected to grow at a CAGR of 19.6%, constrained by statutory health insurance exclusions for anti-obesity medications that limit public reimbursement
